The sleep apnea devices market is set to thrive at a steady CAGR of 9.5% during the forecast period. The market holds a share of US$ 8.2 billion in 2023 while it is anticipated to cross a value of US$ 20.4 billion by 2033.
The research report on sleep apnea devices market explains that the inactive lifestyle of youngsters is exploiting them physically and mentally. Furthermore, conditions like sleep apnea have become quite common in the urban setting. This overall lifestyle has turned people obese, unfit, and ill. Thus, the researchers have found solutions for each of these diseases that are connected to the human lifestyle, directly or indirectly. Sleep apnea is a serious condition that serves to severe cases like stroke, heart arrest, and shortness of oxygen. However, the condition has flourished in the market of sleep apnea devices that provide ease and secure the sleep of the affected patient. Some of these devices involve masks, continuous positive airway pressure (CPAP) machines, etc. The end goal is to maintain a fixed amount of air pressure in the mask, so it keeps the upper airway passages open.
The sleep apnea devices market outlook states that the latest technology of upper airway stimulation (UAS) has been added to the upcoming devices. UAS technology treats sleep apnea with stimulation of muscles that control the tongue from collapsing into the airway. The procedure is minimally invasive, and the result is positive air breathing. Demand for sleep apnea devices is expected to positively drive the market over the forecast period, owing to the focus of extensive research and development by manufacturers to support the healthcare sector with prominent offerings. Through campaigns like 'sleep awareness week,' various organizations and government agencies are focusing on raising awareness and diagnosis rates among these patients, and the market has been expanding at a steady rate.
Attributes
Details
Sleep Apnea Devices Market CAGR (2023 to 2033)
9.5%
Sleep Apnea Devices Market Size (2023)
US$ 8.2 billion
Sleep Apnea Devices Market Size (2033)
US$ 20.4 billion
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
How is the Future Outlook (2023 to 2033) for Sleep Apnea Devices Market in Comparison to the Historical Pattern (2017 to 2022)?
Short-term Growth: From 2017 to 2022, the global sleep apnea devices market registered a comparatively higher CAGR of 6.8%. Technological advancement is expected to propel the demand for sleep apnea devices during the forecast period. Players in the industry are concentrating their efforts on research and development to create innovative technologies. For example, ResMed introduced AirMini, the world's smallest PAP device that is linked to the AirView remote patient monitoring platform.
Mid-term Growth: Patients can view their data on their phones thanks to this device. As a result, the commercialization of such advanced devices hastens the sleep apnea devices market statistics in the coming years. Similarly, recently introduced lightweight, portable CPAP machines, combined with pressure-compensating sensors that can compensate for altitude-related drops in atmospheric pressure, are expected to increase the adoption of sleep apnea devices. The market is likely to grow steadily between 2023 and 2028.
Long-term Growth: New devices for sleep apnea are becoming more popular, as they provide patients with more options and flexibility. As a result, the use of technology-enabled sleep apnea devices for diagnostic and treatment purposes in various sleep disorders is expected to peak in the coming years. The sleep apnea devices market is anticipated to thrive at a CAGR of 9.5% between 2023 and 2033.
North America Drives the Demand for Sleep Apnea Devices to New Heights
North America dominated the sleep apnea devices market in 2020, accounting for 49.0% of total sales. The increasing incidence of respiratory illnesses is causing some sleeping disturbance, boosting the sleep apnea devices market.
Furthermore, rising awareness of sleep apnea, a big patient pool, and foreign manufacturers are expected to boost this region's sleep apnea devices market share. Some of the key participants present in North America are Philips Respironics; Somnetics International Inc.; and ResMed.
Moreover, strategic initiatives by key players have also fueled the market growth. For instance, in October 2021, AirAvant Medical introduced a new device called Bongo Rx for the treatment of obstructive sleep apnea (OSA). The device is touted as a continuous positive airway pressure (CPAP) alternative and is clinically proven to treat mild to moderate OSA symptoms.
Find your sweet spots for generating winning opportunities in this market.
Opportunities for Market Players
The emergence of new devices, such as pressure-compensating sensors, is predicted to skyrocket the overall market growth.
Manufacturers are working hard for research and development of innovative offerings to serve a large customer base, and that may allow the sleep apnea devices market to grow. Hence, manufacturers are adopting strategies such as mergers & acquisitions to expand their global footprint and add disruptive packaging advancements to their product portfolio.
Further, several international market participants are entering into acquisitions and mergers and implementing new technology to increase commercial capacity to gain a leading revenue share.
For instance, in August 2021, connected sleep device maker ResMed released the AirSense 11, one of its latest CPAP machine iterations, which includes a host of new features to treat obstructive sleep apnea. The machine has many of the same specs as ResMed’s previous device, the AirSense 10, but also includes exclusive access to new features.
These include device set-up tutorials on the myAir patient engagement app, personalized care guidance, and remote patient monitoring through the AirView platform. It comes equipped with algorithms that deliver breath-by-breath therapy adjustments and provide nightly breathing data, such as the total amount of times a user spends using CPAP therapy, the number of sleep apnea events per hour, mask leaks, and the number of times the mask was removed. AirSense 11 can also make remote software updates.
Despite their high effectiveness, the action efficacy of machines for sleep apnea is limited in several cases because they require precise and consistent use, as well as constant medical supervision, and the same acts as one of the key factors confining sleep apnea devices' market outlook.
What Factors Are Propelling the Sleep Apnea Devices Market Growth?
The growing awareness of untreated sleep apnea devices markets future trends
The rapidly growing geriatric population suffering from sleep apnea and related health conditions have increased the demand for sleep apnea devices, boosting the sleep apnea device market trends.
The most common sleep-related breathing disorder, obstructive sleep apnea, is associated with a significant disease burden.
Through campaigns like 'sleep awareness week,' various organizations and government agencies are focusing on raising awareness and diagnosis rates among these patients. This is expected to fuel the sleep apnea devices market size even more.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
What Factors Impede the Sleep Apnea Devices Market?
High CPCP machine price negatively affects the sleep apnea devices market around the globe.
Despite the rising prevalence of the disorder and sedentary lifestyle-related diseases around the world, certain factors are limiting the market's growth. One of them is the high CPAP machine cost.
For OSA treatment, PSG and CPAP machines are the best options. The infrastructure and reimbursement systems in developed countries are well-established.
However, developing countries have poor reimbursement systems and high patient out-of-pocket expenses.
This, combined with the low rate of medical coverage in these countries, is limiting the number of patients who can receive treatment there. The sleep apnea devices market growth is being stifled as a result of this.
What Challenges is the Sleep Apnea Devices Market Confronted with?
Treatment adherence, particularly with CPAP, has always been a challenge for sleep apnea patients.
In the short term, this lack of adherence is expected to be a key impediment to the sleep apnea devices adoption trends. However, in the long run, it may have little impact because manufacturers are focusing on making their products more technologically advanced and reducing the drawbacks associated with their adherence to sleep apnea treatment.
The lack of patient compliance with CPAP therapy is a stumbling block in the market's expansion. This is primarily because of a lack of affordability and comfort.
Comparative View of Sleep Apnea Devices Market
Sleep Apnea Devices Market:
Attributes
Sleep Apnea Devices Market
CAGR (2023 to 2033)
9.5%
Market Value (2033)
US$ 129.9 billion
Growth Factor
With campaigns like 'sleep awareness week,' various organizations and government agencies are focusing on raising awareness and diagnosis rates among these patients.
Opportunity
Use of technology-enabled sleep apnea devices for both diagnostic and treatment purposes in a variety of sleep disorders is expected to peak in the coming years.
Key Trends
Players in the industry are concentrating their efforts on research and development in order to create innovative technologies.
Sleep Disorder Market:
Attributes
Sleep Disorder Market
CAGR (2023 to 2033)
6.0%
Market Value (2033)
US$ 28.57 billion
Growth Factor
The availability of effective diagnosis and treatment for the disorder, and increasing expenditure on healthcare, is expected to fuel market growth.
Opportunity
Technological advances, such as the development of advanced sleep diagnostic and therapeutic devices, may drive the growth of the sleep disorder market.
Key Trends
The increasing number of new product launches, as well as the region's high penetration of key players, are driving up market demand.
CPAP Devices Market:
Attributes
CPAP Devices Market
CAGR (2023 to 2033)
9.1%
Market Value (2033)
US$ 9.20 billion
Growth Factor
The rising prevalence of sleep apnea disorder worldwide is a result of obesity, rising cardiovascular disease, diabetes, and other such diseases.
Opportunity
Advances in technology, as well as a scarcity of ventilators during the COVID-19 pandemic, contribute to the adoption of CPAP devices.
Key Trends
Rising patient adherence to pressure devices around the world and improving healthcare infrastructure.
Country-wise Insights
Region
Absolute Market Growth
United States
US$ 5.6 billion
Germany
US$ 367.6 million
Japan
US$ 698.8 million
China
US$ 534.7 million
Australia
US$ 294.7 million
Which Region leads the Market in terms of Market Share and CAGR?
Rising Cases of Stroke and Obesity in the United States are Booming the Regional Market Growth
United States Market CAGR (2023 to 2033)
9.3%
United States Market Absolute Doller Growth (US$ million/billion)
US$ 5.6 billion
United States leads the sleep apnea devices market with a CAGR of 9.3% between 2023 and 2033, while reaching a value of US$ 9.5 billion by 2033. Rising awareness of sleep apnea, a big patient pool, and foreign manufacturers are expected to boost this region's sleep apnea devices market share. Furthermore, the number of therapeutic tests for establishing the presence of sleep apnea in the region is fast increasing, as many people are concerned about the health concerns associated with this illness.
What Makes Japan a Leading Sleep Apnea Devices Market in terms of CAGR?
Region
Attributes
Japanese Market CAGR (2023 to 2033)
8.8%
Japanese Market Absolute Doller Growth (US$ million/billion)
US$ 3.2 billion
Japan sleep apnea devices market is anticipated to flourish at a steady CAGR of 8.9% during the forecast period. The regional market is anticipated to reach a value of US$ 1.2 billion
The sleep apnea devices market in Japan is expected to rise at a rapid pace over the forecast period. The Japanese sleep apnea devices market is being driven by a growing elderly population and an increase in the prevalence of lifestyle illnesses.
According to the WHO, chronic respiratory illnesses, diabetes, cardiovascular diseases, and cancer are some of the top causes of mortality in the region.
According to the IDF Diabetes Atlas 9th Edition, about 87.6 million persons in the South East Asia area are diabetic, ranging in age from 20 to 79 years. With the incidence of chronic diseases on the rise, Japan is projected to see an increase in the use of sleep apnea devices. According to a PubMed study, the prevalence of obstructive sleep apnea in middle-aged Asian men ranges from 4.1% to 7.5% and 2.1% to 3.2% in females.
Category-wise Insights
Segment
Top Product
Top Sub-segment
Therapeutics
CAGR (2017 to 2022)
6.6%
CAGR (2023 to 2033)
9.4%
Segment
Top End User
Top Sub-segment
Sleep Laboratories & Hospitals
CAGR (2017 to 2022)
6.4%
CAGR (2023 to 2033)
9.1%
Higher Inclusivity and Patient Comfort are Propelling the Growth of the Therapeutic Segment
The therapeutic devices category dominated the sleep apnea devices market, based on product. The therapeutic devices category is expected to lead the sleep apnea devices market with a CAGR of 9.4% between 2023 and 2033. Continuous positive airway pressure treatment (CPAP) employs a CPAP machine to assist a person suffering from obstructive sleep apnea (OSA) in breathing more comfortably while sleeping. A CPAP machine raises the pressure in your throat, preventing your airway from collapsing as you breathe in.
Higher Consumption and Expanding Research and Development Are Flourishing the Sales for the Sleep Laboratories & Hospitals Segment
The sleep laboratories and hospitals sector held the greatest proportion of the sleep apnea devices market. The higher consumption and extended research facilities are making this end-user segment the fast-growing segment in the market. Government spending big chunks on healthcare advancement and techniques are also thriving the sales of sleep apnea devices. The segment thrives at a steady CAGR of 9.1% between 2023 and 2033.
Competition Scenario
Key businesses like ResMed, Philips Respironics, and Somnetics International, Inc. have built a significant presence in the region, as well as strong distribution networks to ensure a simple supply of their goods.
The fierce rivalry among sleep apnea devices market competitors to extend their regional footprints and increase their client pool through multiple product releases and new product innovations is expected to drive the sleep apnea devices market over the projected period.
Market Developments
In February 2021, Nyxoah SA, the maker of the Obstructive Sleep Apnea (OSA) neurostimulator device, collaborated with Vanderbilt University to develop innovative neurostimulation options for OSA therapy.
Fisher & Paykel Healthcare introduced F&P Evora, a revolutionary nasal mask designed for obstructive sleep apnea (OSA) therapy. Furthermore, the integration of computer-assisted development and production may lead to new advancements in gadgets that allow for greater flexibility of movement while sleeping.
Itamar Medical has received FDA certification for its WatchPAT One, a single-use home sleep apnea test. These tests provide the great level of precision and dependability for patients in in-home care settings. Such product advancements are projected to increase the adoption of sleep apnea devices in in-home care settings.
Key Contributors of the Market
BMC Medical Co., Ltd.
LivaNova PLC
Cadwell Laboratories Inc.
Fisher & Paykel Healthcare
Invacare Corporation
Itamar Medical Ltd
Natus Medical Inc.
Nihon Kohden
Koninklijke Philips N.V.
ResMed Inc.
Teleflex Inc.
Drive DeVilbiss International
Key Segments
By Product:
Therapeutics
Airway Clearance Systems
Adaptive Servo-ventilation (ASV)
Positive Airway Pressure (PAP) Device
Oral Appliances
Oxygen Devices
Others
Diagnostics
Actigraphy Systems
Polysomnography (PSG) Device
Respiratory Polygraph
Sleep Screening Devices
By End User:
Home Care Settings & Individuals
Sleep Laboratories & Hospitals
By Region
North America
Latin America
Europe
Asia Pacific (APAC)
The Middle East & Africa (MEA)
Frequently Asked Questions
The sleep apnea devices market holds a valuation of US$ 8.2 billion in 2023.
The projected value of the sleep apnea devices market is anticipated to attain US$ 20.4 billion by 2033.
The sleep apnea devices market is anticipated to register a CAGR of 9.5% through 2033.
The sleep apnea devices market in the United States is poised for lucrative growth, targeting a US$ 5.6 billion market size by 2033 with a robust 9.3% CAGR.
The global demand for sleep apnea devices experienced a CAGR of 6.8% between 2018 and 2022.
Table of Content
1. Executive Summary | Sleep Apnea Devices Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2017 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Therapeutics
5.3.1.1. Airway Clearance Systems
5.3.1.2. Adaptive Servo-ventilation
5.3.1.3. Positive Airway Pressure Device
5.3.1.4. Oral Appliances
5.3.1.5. Oxygen Devices
5.3.1.6. Others
5.3.2. Diagnostics
5.3.2.1. Actigraphy Systems
5.3.2.2. Polysomnography Device
5.3.2.3. Respiratory Polygraph
5.3.2.4. Sleep Screening Devices
5.4. Y-o-Y Growth Trend Analysis By Product, 2017 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033
6.3.1. Home Care Settings & Individuals
6.3.2. Sleep Laboratories & Hospitals
6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022
6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Product
8.2.3. By End User
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product
8.3.3. By End User
8.4. Key Takeaways
9. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Product
9.2.3. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By End User
9.4. Key Takeaways
10. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. United Kingdom
10.2.1.2. Spain
10.2.1.3. Germany
10.2.1.4. Italy
10.2.1.5. France
10.2.1.6. Rest of Europe
10.2.2. By Product
10.2.3. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By End User
10.4. Key Takeaways
11. Asia Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. India
11.2.1.2. China
11.2.1.3. Japan
11.2.1.4. Australia
11.2.1.5. Rest of Asia Pacific
11.2.2. By Product
11.2.3. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By End User
11.4. Key Takeaways
12. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. South Africa
12.2.1.2. GCC Countries
12.2.1.3. Rest of Middle East and Africa
12.2.2. By Product
12.2.3. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By End User
12.4. Key Takeaways
13. Key Countries Market Analysis
13.1. USA
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2022
13.1.2.1. By Product
13.1.2.2. By End User
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2022
13.2.2.1. By Product
13.2.2.2. By End User
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2022
13.3.2.1. By Product
13.3.2.2. By End User
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2022
13.4.2.1. By Product
13.4.2.2. By End User
13.5. United Kingdom
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2022
13.5.2.1. By Product
13.5.2.2. By End User
13.6. Spain
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2022
13.6.2.1. By Product
13.6.2.2. By End User
13.7. Germany
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2022
13.7.2.1. By Product
13.7.2.2. By End User
13.8. Italy
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2022
13.8.2.1. By Product
13.8.2.2. By End User
13.9. France
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2022
13.9.2.1. By Product
13.9.2.2. By End User
13.10. India
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2022
13.10.2.1. By Product
13.10.2.2. By End User
13.11. China
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2022
13.11.2.1. By Product
13.11.2.2. By End User
13.12. Japan
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2022
13.12.2.1. By Product
13.12.2.2. By End User
13.13. Australia & New Zealand
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2022
13.13.2.1. By Product
13.13.2.2. By End User
13.14. South Africa
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2022
13.14.2.1. By Product
13.14.2.2. By End User
13.15. GCC Countries
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2022
13.15.2.1. By Product
13.15.2.2. By End User
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Product
14.3.3. By End User
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. BMC Medical Co., Ltd.
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. LivaNova PLC
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. Cadwell Laboratories Inc.
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.4. Fisher & Paykel Healthcare
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.5. Invacare Corporation
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.6. Itamar Medical Ltd
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.7. Natus Medical Inc.
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.8. Nihon Kohden
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.9. Koninklijke Philips N.V.
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.10. ResMed Inc.
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segments
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
15.1.11. Teleflex Inc.
15.1.11.1. Overview
15.1.11.2. Product Portfolio
15.1.11.3. Profitability by Market Segments
15.1.11.4. Sales Footprint
15.1.11.5. Strategy Overview
15.1.11.5.1. Marketing Strategy
15.1.12. Drive DeVilbiss International
15.1.12.1. Overview
15.1.12.2. Product Portfolio
15.1.12.3. Profitability by Market Segments
15.1.12.4. Sales Footprint
15.1.12.5. Strategy Overview
15.1.12.5.1. Marketing Strategy
16. Assumptions & Acronyms Used17. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2033
Table 2: Global Market Value (US$ Million) Forecast by Product, 2017 to 2033
Table 3: Global Market Value (US$ Million) Forecast by End User, 2017 to 2033
Table 4: North America Market Value (US$ Million) Forecast by Country, 2017 to 2033
Table 5: North America Market Value (US$ Million) Forecast by Product, 2017 to 2033
Table 6: North America Market Value (US$ Million) Forecast by End User, 2017 to 2033
Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2033
Table 8: Latin America Market Value (US$ Million) Forecast by Product, 2017 to 2033
Table 9: Latin America Market Value (US$ Million) Forecast by End User, 2017 to 2033
Table 10: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2033
Table 11: Europe Market Value (US$ Million) Forecast by Product, 2017 to 2033
Table 12: Europe Market Value (US$ Million) Forecast by End User, 2017 to 2033
Table 13: Asia Pacific Market Value (US$ Million) Forecast by Country, 2017 to 2033
Table 14: Asia Pacific Market Value (US$ Million) Forecast by Product, 2017 to 2033
Table 15: Asia Pacific Market Value (US$ Million) Forecast by End User, 2017 to 2033
Table 16: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2017 to 2033
Table 17: Middle East and Africa Market Value (US$ Million) Forecast by Product, 2017 to 2033
Table 18: Middle East and Africa Market Value (US$ Million) Forecast by End User, 2017 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Product, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by End User, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 4: Global Market Value (US$ Million) Analysis by Region, 2017 to 2033
Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 7: Global Market Value (US$ Million) Analysis by Product, 2017 to 2033
Figure 8: Global Market Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 9: Global Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 10: Global Market Value (US$ Million) Analysis by End User, 2017 to 2033
Figure 11: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 12: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 13: Global Market Attractiveness by Product, 2023 to 2033
Figure 14: Global Market Attractiveness by End User, 2023 to 2033
Figure 15: Global Market Attractiveness by Region, 2023 to 2033
Figure 16: North America Market Value (US$ Million) by Product, 2023 to 2033
Figure 17: North America Market Value (US$ Million) by End User, 2023 to 2033
Figure 18: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 19: North America Market Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 22: North America Market Value (US$ Million) Analysis by Product, 2017 to 2033
Figure 23: North America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 24: North America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 25: North America Market Value (US$ Million) Analysis by End User, 2017 to 2033
Figure 26: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 27: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 28: North America Market Attractiveness by Product, 2023 to 2033
Figure 29: North America Market Attractiveness by End User, 2023 to 2033
Figure 30: North America Market Attractiveness by Country, 2023 to 2033
Figure 31: Latin America Market Value (US$ Million) by Product, 2023 to 2033
Figure 32: Latin America Market Value (US$ Million) by End User, 2023 to 2033
Figure 33: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 37: Latin America Market Value (US$ Million) Analysis by Product, 2017 to 2033
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 40: Latin America Market Value (US$ Million) Analysis by End User, 2017 to 2033
Figure 41: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 43: Latin America Market Attractiveness by Product, 2023 to 2033
Figure 44: Latin America Market Attractiveness by End User, 2023 to 2033
Figure 45: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 46: Europe Market Value (US$ Million) by Product, 2023 to 2033
Figure 47: Europe Market Value (US$ Million) by End User, 2023 to 2033
Figure 48: Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 49: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 52: Europe Market Value (US$ Million) Analysis by Product, 2017 to 2033
Figure 53: Europe Market Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 54: Europe Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 55: Europe Market Value (US$ Million) Analysis by End User, 2017 to 2033
Figure 56: Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 57: Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 58: Europe Market Attractiveness by Product, 2023 to 2033
Figure 59: Europe Market Attractiveness by End User, 2023 to 2033
Figure 60: Europe Market Attractiveness by Country, 2023 to 2033
Figure 61: Asia Pacific Market Value (US$ Million) by Product, 2023 to 2033
Figure 62: Asia Pacific Market Value (US$ Million) by End User, 2023 to 2033
Figure 63: Asia Pacific Market Value (US$ Million) by Country, 2023 to 2033
Figure 64: Asia Pacific Market Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 65: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 66: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 67: Asia Pacific Market Value (US$ Million) Analysis by Product, 2017 to 2033
Figure 68: Asia Pacific Market Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 69: Asia Pacific Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 70: Asia Pacific Market Value (US$ Million) Analysis by End User, 2017 to 2033
Figure 71: Asia Pacific Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 72: Asia Pacific Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 73: Asia Pacific Market Attractiveness by Product, 2023 to 2033
Figure 74: Asia Pacific Market Attractiveness by End User, 2023 to 2033
Figure 75: Asia Pacific Market Attractiveness by Country, 2023 to 2033
Figure 76: Middle East and Africa Market Value (US$ Million) by Product, 2023 to 2033
Figure 77: Middle East and Africa Market Value (US$ Million) by End User, 2023 to 2033
Figure 78: Middle East and Africa Market Value (US$ Million) by Country, 2023 to 2033
Figure 79: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 80: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 81: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 82: Middle East and Africa Market Value (US$ Million) Analysis by Product, 2017 to 2033
Figure 83: Middle East and Africa Market Value Share (%) and BPS Analysis by Product, 2023 to 2033
Figure 84: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033
Figure 85: Middle East and Africa Market Value (US$ Million) Analysis by End User, 2017 to 2033
Figure 86: Middle East and Africa Market Value Share (%) and BPS Analysis by End User, 2023 to 2033
Figure 87: Middle East and Africa Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033
Figure 88: Middle East and Africa Market Attractiveness by Product, 2023 to 2033
Figure 89: Middle East and Africa Market Attractiveness by End User, 2023 to 2033
Figure 90: Middle East and Africa Market Attractiveness by Country, 2023 to 2033
